CD28 and angioimmunoblastic T-cell lymphoma: Actually, it was known that half of AITL have mutations in the TCR signaling pathways, including CD28 (13%), FYN (4.2%), PLCG1 (7.5%), STAT3 (3.1%), and VAV1 (4.3%) [31, 43].